Rikke S. Møller
@rikkesmoller.bsky.social
520 followers 280 following 54 posts
Geneticist/Professor at the Danish Epilepsy Centre, Filadelfia & University of Southern Denmark 🇩🇰 I Epilepsy 💜 | Precision Medicine 💊 I Genetics 🧬 | Rare Disease 🦓 |
Posts Media Videos Starter Packs
rikkesmoller.bsky.social
Exciting Announcement‼️

Thrilled to be working on the program for the 7th Dianalund International Conference on #Epilepsy 🤩

⭐️ The topic is "Developmental and Epileptic Encephalopathies: From Mechanisms to Action" 🤩

📅 May 6-8, 2026, in Køge, Denmark 🇩🇰

#DICE2026
@torierobinson.bsky.social
rikkesmoller.bsky.social
Publication alert 📢 The genetic and phenotypic spectrum of #GABRB1-related disorders 🧠

We present a comprehensive analysis of GABRB1 variants, by revealing their functional implications, establishing genotype-phenotype correlations & evaluating treatment response ‼️
academic.oup.com/brain/advanc...
The genetic and phenotypic spectrum of GABRB1-related disorders
Millevert et al. studied genetic variants in the GABRB1 gene associated with epilepsy. Analysis of functional effects and clinical data from 19 individuals
academic.oup.com
Reposted by Rikke S. Møller
sbaulac.bsky.social
📢 Paper out! Focal Cortical Dysplasia-linked epilepsy is more complex than expected - somatic mTOR-activating mutations affect multiple cell lineages, yet only a fraction become cytomegalic. Dysmorphic neurons show mitochondrial dysfunction. #Epilepsy #BrainMosaicism #Neurodevelopment
rikkesmoller.bsky.social
Dreaming of a career in neuroscience 🧠?

Neuroscience Academy Denmark @naddenmark.bsky.social offers 16 fully funded PhD fellowships to exceptional and highly motivated candidates‼️

📅 Application deadline: August 11, 2025

Learn more about NAD at 👉 neuroscienceacademydenmark.dk
rikkesmoller.bsky.social
Publication alert 📢 The severity of #SLC1A2-associated neurodevelopmental disorders correlates with transporter dysfunction 🧬🧠

⭐️ 3 distinct molecular and clinical phenotypes were observed ‼️

Great multicenter collaborative effort led by scientists in 🇩🇰 & 🇩🇪

www.sciencedirect.com/science/arti...
The severity of SLC1A2-associated neurodevelopmental disorders correlates with transporter dysfunction
Excitatory amino acid transporter 2 (EAAT2) is the predominant glutamate transporter and a key mediator of excitatory neurotransmission in the human b…
www.sciencedirect.com
rikkesmoller.bsky.social
Heading home after a fantastic Troina meeting on #genetics 🧬 of neurodevelopmental disorders 🇮🇹

Exciting and inspiring talks and discussions, & lovely to see old friends & colleagues from around the world 🤩
#Epilepsy

@hcmefford.bsky.social @bertdevries.bsky.social @naelnadifkasri-lab.bsky.social
Reposted by Rikke S. Møller
torierobinson.bsky.social
Child neurologist Matthias De Wachter 🤩 and I are chatting on the podcast 🎙️ re the often-overlooked aspects of #epilepsy 😮!
We explore:
🔹 Symptoms beyond seizures
🔹 Lifestyle impacts
🔹 Paediatric to adult care
🔹 Drug repurposing
🔹 Research on rare epilepsies
Links in next post below 👇🏻!
rikkesmoller.bsky.social
One of the missions of EpiCARE (the European Reference Network for rare and complex epilepsies) is to promote clinical research on genetic epilepsies 🧠

Check out the webpage for collaborative research calls incl. our recent call on #SCN2A-related episodic ataxia and alternating hemiplegia 👇
rikkesmoller.bsky.social
Thanks for your message @imperfectpitch.bsky.social 😊 You can contact SCN2A Europe here 👉 www.scn2a.eu/contact 🤩

You are also welcome to send me a DM 😊

#StrongerTogether
Contact
www.scn2a.eu
rikkesmoller.bsky.social
Thrilled to share the program for the 3rd #SCN2A and #SCN8A scientific conference and family gathering 🤩

📅 May 16th-17th, 2025

📍 Bonn, Germany

⭐ Registration is free of charge 👉 lets-meet.org/reg/b7f4598e...

Join us in Bonn to learn more about SCN2A and SCN8A related disorders 💜
rikkesmoller.bsky.social
Today the amazing @agustinafernandez.bsky.social from Cure GABAA Variants and her lovely family visited the Danish Epilepsy Centre 😍

It was a great pleasure to showcase our beautiful center, to share progress & to discuss future collaborations 😊

Together, we can drive change ‼️

#StrongerTogether 💜
rikkesmoller.bsky.social
Welcome to Bluesky @vangroovymom.bsky.social 🦋

I have added you to the Rare Genetic Epilepsies Starter Pack 🧠🧬
#DCX #FLNA #PVNH
Reposted by Rikke S. Møller
katjakobow.bsky.social
Calling any trainees and early career researchers interested in epilepsy and new drug development - places still remain on this summer's Advanced Epilepsy Course, held in San Servolo, Venice, Italy!

www.ilae.org/congresses/2...
Course summary and registration details for the San Servolo Advanced Epilepsy Course 2025 on Bridging Basic Science with Clinical Epileptology. Course takes place in Venice from July 21 to August 1 and will address the role of non-neuronal cells in epilepsy.
rikkesmoller.bsky.social
Welcome to Bluesky 🦋 @katrinemjohannesen.bsky.social 🥳 I have added you to the Rare Genetic Epilepsies Starter Pack 🧠🧬

#SLC6A1 #GABAA-receptor related disorders
rikkesmoller.bsky.social
Welcome to Bluesky 🦋 @eheinzen.bsky.social 😊 I have added you to the Rare Genetic Epilepsies Starter Pack 🧠🧬
rikkesmoller.bsky.social
Welcome to Bluesky 😊, I have added you to the Rare Genetic Epilepsies Starter Pack 🧠🧬
Reposted by Rikke S. Møller
epilepsiajournal.bsky.social
Key point: Cenobamate is a promising and safe treatment for SCN8A-related DEEs, even during early childhood.
doi.org/10.1111/epi....

#epilepsy #ILAE #drugresistantepilepsy #geneticepilepsy #sodiumchannelopathy #DEE
rikkesmoller.bsky.social
Great pleasure to attend the Synapse Biology in Health and Disease Symposium at University of Copenhagen 🇩🇰

Lots of interesting talks incl. exciting presentations on SNAREopathies/#STXBP1-related disorders 🧠🧬

Grateful for the opportunity to share insights on #GABAA-receptor related disorders 🤩
rikkesmoller.bsky.social
Sure thing 🤩 - you have now been added 👍
Reposted by Rikke S. Møller
madeleineoudin.bsky.social
Excited to see this paper out - Cenobamate has helped Margot so much and I hope this data will help expand access for pediatric patients.
rikkesmoller.bsky.social
Publication alert 📢 Cenobamate as add-on treatment SCN8A-DEE ‼️

⭐️ Our data suggest that cenobamate is a promising and safe treatment even during early childhood ‼️

Excellent work by Cathrine Gjerulfsen & Madeleine Oudin 💪👏

#Epilepsy 🧠 #Genetics 🧬

onlinelibrary.wiley.com/doi/abs/10.1...
Cenobamate as add‐on treatment for SCN8A developmental and epileptic encephalopathy
Cenobamate is a promising and safe treatment for SCN8A-DEE, even during early childhood. As a potential precision approach to treatment, cenobamate significantly reduced seizure burden and improved n...
onlinelibrary.wiley.com
rikkesmoller.bsky.social
Welcome to Bluesky 🦋 @lignanilab.bsky.social 🤩 I have added you to the rare genetic epilepsies starter pack 🧠🧬
#DravetSyndrome #GeneTherapy #CRISPR
rikkesmoller.bsky.social
Welcome to Bluesky @katjakobow.bsky.social 🤩
I have added you to the starter pack on rare genetic epilepsies 🧠🧬
#FCDs #Epigenetics #MOGHE #SLC35A2
rikkesmoller.bsky.social
Welcome to Bluesky Peter (@epilepsy-sci.bsky.social). I have added you to the rare #epilepsy starter pack 🤩

#KCNA2 #KCNA1 #SCN1A
rikkesmoller.bsky.social
New preprint alert 📢 The natural history of #CDKL5 deficiency disorder into adulthood ❗

Our findings will inform management decisions, prognostication, and the design of clinical trials ‼️

Angel Aledo-Serrano & David Lewis-Smith 💪👏

#Epilepsy 🧠 #Genetics 🧬

www.medrxiv.org/content/10.1...
The natural history of CDKL5 deficiency disorder into adulthood
Knowledge of the natural history of CDKL5 deficiency disorder (CDD) is limited to the results of cross-sectional analysis of largely pediatric cohorts. Assessment of outcomes in adulthood is critical ...
www.medrxiv.org